Montelukast attenuates experimental food allergy and reduces colonic eosinophilic inflammation

BACKGROUND: Montelukast, a cysteinyl leukotriene receptor antagonist, may modulate eosinophilic inflammation and immune regulation in food allergy, but its effects in intestinal allergic inflammation remain unclear. METHODS: The effects of pre-challenge montelukast administration were evaluated in an ovalbumin-induced mouse model of food allergy. Mice were assigned to Control, montelukast-treated, ovalbumin-sensitized, and montelukast-treated ovalbumin-sensitized groups. Allergic responses, serum ovalbumin-specific immunoglobulin E, colonic eosinophil infiltration, Foxp3 expression, and epithelial adhesion proteins were assessed. RESULTS: Time-point specific comparisons showed lower anaphylaxis scores and a smaller reduction in rectal temperature in the ML+OVA group than in the OVA group at selected post challenge time points. Montelukast also reduced colonic eosinophilic infiltration in ovalbumin-sensitized mice. Colonic Foxp3 protein expression was increased, whereas Foxp3 immunohistochemical staining showed no statistically significant difference between the ovalbumin and montelukast-treated ovalbumin groups. Montelukast did not restore the ovalbumin-associated reduction in E-cadherin expression, although N-cadherin expression tended to be lower after treatment. In exploratory correlation analyses of data pooled across all experimental groups, eosinophil infiltration and E-cadherin expression showed opposing associations with allergic symptom severity. CONCLUSION: Pre-challenge montelukast administration attenuated experimental food-allergic responses, primarily in association with reduced colonic eosinophilic inflammation. Although colonic Foxp3 protein expression increased, Foxp3 immunohistochemical staining did not differ significantly between the OVA and ML+OVA groups; therefore, these findings do not establish a change in Treg abundance or function.

Authors

Publication Details

Journal
International Archives of Allergy and Immunology
Published
2026-11-18
DOI
https://doi.org/10.1159/iaa/adfag040
Primary Topic
Food Allergy and Anaphylaxis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Montelukast attenuates experimental food allergy and reduces colonic eosinophilic inflammation

Eun-ae Yang, Jong Ok Kim, Jung-Woo Rhim, Hyeongjwa Choi et al.
International Archives of Allergy and Immunology
Food Allergy and Anaphylaxis Research
article

Montelukast attenuates experimental food allergy and reduces colonic eosinophilic inflammation

Eun-ae Yang, Jong Ok Kim, Jung-Woo Rhim, Hyeongjwa Choi, Jayoung Lee, Jeong-Min Oh
article en

Abstract

BACKGROUND: Montelukast, a cysteinyl leukotriene receptor antagonist, may modulate eosinophilic inflammation and immune regulation in food allergy, but its effects in intestinal allergic inflammation remain unclear. METHODS: The effects of pre-challenge montelukast administration were evaluated in an ovalbumin-induced mouse model of food allergy. Mice were assigned to Control, montelukast-treated, ovalbumin-sensitized, and montelukast-treated ovalbumin-sensitized groups. Allergic responses, serum ovalbumin-specific immunoglobulin E, colonic eosinophil infiltration, Foxp3 expression, and epithelial adhesion proteins were assessed. RESULTS: Time-point specific comparisons showed lower anaphylaxis scores and a smaller reduction in rectal temperature in the ML+OVA group than in the OVA group at selected post challenge time points. Montelukast also reduced colonic eosinophilic infiltration in ovalbumin-sensitized mice. Colonic Foxp3 protein expression was increased, whereas Foxp3 immunohistochemical staining showed no statistically significant difference between the ovalbumin and montelukast-treated ovalbumin groups. Montelukast did not restore the ovalbumin-associated reduction in E-cadherin expression, although N-cadherin expression tended to be lower after treatment. In exploratory correlation analyses of data pooled across all experimental groups, eosinophil infiltration and E-cadherin expression showed opposing associations with allergic symptom severity. CONCLUSION: Pre-challenge montelukast administration attenuated experimental food-allergic responses, primarily in association with reduced colonic eosinophilic inflammation. Although colonic Foxp3 protein expression increased, Foxp3 immunohistochemical staining did not differ significantly between the OVA and ML+OVA groups; therefore, these findings do not establish a change in Treg abundance or function.

International Archives of Allergy and Immunology
Good health and well-being
Food Allergy and Anaphylaxis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon